Tredegar Corporation

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Executive Officer Transition On November 19, 2025, John M. Steitz informed Tredegar Corporation (the “Company”) of his intention to retire as the Company’s President and Chief Executive Officer and from the Company’s Board of Directors (the “Board”), effective December 31, 2025. On November 20, 2025, the Board elected Arijit (Bapi) DasGupta, who currently serves as the Company’s President, Surface Protection, as the Company’s President and Chief Executive Officer, effective January 1, 2026. Dr. DasGupta will serve in this role in addition to his current positions at the Company. Dr. DasGupta, 68, joined the Company in 2007 and has led its PE Films business unit, serving as its President, since 2015. Dr. DasGupta previously held various leadership roles for the Company’s PE Films business. Prior to joining the Company, he held leadership positions at Johns Manville, Solutia and Monsanto. In connection with Dr. DasGupta’s election as the Company’s President and Chief Executive Officer, the Board also elected Dr. DasGupta to the Board, effective January 1, 2026, to fill the vacancy created by Mr. Steitz’s retirement. Chief Financial Officer Transition As previously disclosed, D. Andrew Edwards, Executive Vice President and Chief Financial Officer of the Company, will retire effective December 31, 2025. On November 20, 2025, the Board elected Frasier W. Brickhouse, II, who currently serves as the Company’s Corporate Treasurer and Controller, as the Company’s Vice President and Chief Financial Officer, effective as of January 1, 2026. Mr. Brickhouse will serve in this role in addition to his current positions at the Company. Mr. Brickhouse, 59, joined the Company in 1993 and was appointed Corporate Controller in 2009 and Treasurer in 2016. He previously served in various treasury, accounting and financial planning roles within the Company. Prior to joining the Company, Mr. Brickhouse spent five years in various positions of increasing responsibility with Coopers & Lybrand (predecessor to PricewaterhouseCoopers LLP). There are no arrangements or understandings between Dr. DasGupta or Mr. Brickhouse and any other persons pursuant to which they were selected as an officer or director, as applicable, and neither has any family relationships with any of the Company’s directors or executive officers. Additionally, neither Dr. DasGupta nor Mr. Brickhouse has a direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Any compensation adjustments in connection with Dr. DasGupta’s or Mr. Brickhouse’s elections as the Company’s President and Chief Executive Officer and Vice President and Chief Financial Officer, respectively, have not been determined.

Item 7.01. Regulation FD Disclosure. On November 20, 2025, in connection with the matters disclosed in Item 5.02 of this Current Report on Form 8-K, the Company issued a press release, a copy of which is attached as Exhibit 99.1 and incorporated by reference in this Item 7.01. In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.